logo-large
  • Browse Categories

Publications by authors named "Constanza Linossi"

Claim this Profile
F
First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors.
Richard D Baird, Constanza Linossi, Mark Middleton, Simon Lord, Adrian Harris

J Clin Oncol· January 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
SriGanesh Jammula, Annalise C Katz-Summercorn, Xiaodun Li, Constanza Linossi, Elizabeth Smyth

Gastroenterology· May 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.
Richard D Baird, Annelot G J van Rossum, Mafalda Oliveira, Karin Beelen, Meiling Gao, Constanza Linossi

Clin Cancer Res· November 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: